XRAY EV/EBITDA Analysis

EV/EBITDA compares a company's total value to its earnings before interest, taxes, depreciation, and amortization, so 8.4x means investors pay $8.40 for every $1 of operating cash profit.

This is well below the sector median of 13.5x, placing XRAY at the 25th percentile among peers — cheaper than most. The metric is stable over the last eight quarters, with the most recent quarter dipping 2.7% quarter-over-quarter; a year-over-year figure is not available. The combination of a low valuation and a stable trend suggests limited downside risk but also no immediate catalyst for a re-rating. For an investor, this level implies the stock is not expensive, yet the lack of movement points to muted expectations. This supports the overall NEUTRAL verdict: the valuation is attractive enough to avoid a sell, but not compelling enough to warrant a buy.

Frequently Asked Questions